These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10873957)

  • 1. Consensus statement on the initiation and continuation of tumour necrosis factor blocking therapies in rheumatoid arthritis.
    Smolen JS; Breedveld FC; Burmester GR; Combe B; Emery P; Kalden JR; Klareskog L; Maini RN; Numo R; van De Putte LB; van Riel PL; Rodriguez-Valverde V
    Ann Rheum Dis; 2000 Jul; 59(7):504-5. PubMed ID: 10873957
    [No Abstract]   [Full Text] [Related]  

  • 2. Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis (May 2000).
    Furst DE; Breedveld FC; Burmester GR; Crofford JJ; Emery P; Feldmann M; Kalden JR; Kavanaugh AF; Keystone EC; Klareskog LG; Lipsky PE; Maini RN; Russell AS; Scott DL; Smolen JS; Van de Putte LB; Visher TL; Weisman MH
    Ann Rheum Dis; 2000 Nov; 59 Suppl 1(Suppl 1):i1-2. PubMed ID: 11053077
    [No Abstract]   [Full Text] [Related]  

  • 3. Treating rheumatoid arthritis with tumour necrosis factor alpha blockade.
    Emery P; Buch M
    BMJ; 2002 Feb; 324(7333):312-3. PubMed ID: 11834544
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe.
    Emery P; Van Vollenhoven R; Ostergaard M; Choy E; Combe B; Graninger W; Krueger K; Matucci-Cerinic M; Navarro F; van Riel P; Settas L; Steinfeld S
    Ann Rheum Dis; 2009 Apr; 68(4):456-9. PubMed ID: 19286904
    [No Abstract]   [Full Text] [Related]  

  • 5. Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other rheumatic diseases (May 2002).
    Furst DE; Breedveld FC; Kalden JR; Smolen JS; Antoni CE; Bijlsma JW; Burmester GR; Cronstein B; Keystone EC; Kavanaugh A; Klareskog L
    Ann Rheum Dis; 2002 Nov; 61 Suppl 2(Suppl 2):ii2-7. PubMed ID: 12379612
    [No Abstract]   [Full Text] [Related]  

  • 6. Updating the British Society for Rheumatology guidelines for anti-tumour necrosis factor therapy in adult rheumatoid arthritis (again).
    Deighton CM; George E; Kiely PD; Ledingham J; Luqmani RA; Scott DG
    Rheumatology (Oxford); 2006 Jun; 45(6):649-52. PubMed ID: 16527881
    [No Abstract]   [Full Text] [Related]  

  • 7. Do we need therapeutic trials comparing biotherapies to guide treatment selection in patients with rheumatoid arthritis?
    Dougados M
    Joint Bone Spine; 2013 Oct; 80(5):443-5. PubMed ID: 23747071
    [No Abstract]   [Full Text] [Related]  

  • 8. Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005.
    Furst DE; Breedveld FC; Kalden JR; Smolen JS; Burmester GR; Bijlsma JW; Dougados M; Emery P; Keystone EC; Klareskog L; Mease PJ
    Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv2-14. PubMed ID: 16239380
    [No Abstract]   [Full Text] [Related]  

  • 9. Building towards a consensus for the use of tumour necrosis factor blocking agents.
    Furst DE; Breedveld FC; Kalden JR; Smolen JS
    Ann Rheum Dis; 1999 Dec; 58(12):725-6. PubMed ID: 10577955
    [No Abstract]   [Full Text] [Related]  

  • 10. Access to disease modifying treatments for rheumatoid arthritis patients.
    Furst DE; Breedveld FC; Burmester GR; Crofford L; Emery P; Feldman M; Kalden JR; Kavanaugh A; Keystone E; Lipsky PE; Maini RN; Moreland L; Smolen JS; Van De Putte L; Vischer T; Weinblatt M; Weissman M
    Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I129-30. PubMed ID: 10577989
    [No Abstract]   [Full Text] [Related]  

  • 11. TNF-blocking therapies: an alternative mode of action?
    Choo-Kang BS; Hutchison S; Nickdel MB; Bundick RV; Leishman AJ; Brewer JM; McInnes IB; Garside P
    Trends Immunol; 2005 Oct; 26(10):518-22. PubMed ID: 16087401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adalimumab (a fully human anti-tumour necrosis factor alpha monoclonal antibody) in the treatment of active rheumatoid arthritis: the initial results of five trials.
    Rau R
    Ann Rheum Dis; 2002 Nov; 61 Suppl 2(Suppl 2):ii70-3. PubMed ID: 12379628
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effectiveness estimates reported for tumor necrosis factor blocking agents in rheumatoid arthritis refractory to methotrexate--a brief summary.
    Maetzel A
    J Rheumatol Suppl; 2005 Jan; 72():51-3. PubMed ID: 15660469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological therapies for rheumatoid arthritis.
    Edwards CJ
    Br Med Bull; 2005; 73-74():71-82. PubMed ID: 16174791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Summary of clinical trials in rheumatoid arthritis using infliximab, an anti-TNFalpha treatment.
    Harriman G; Harper LK; Schaible TF
    Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I61-4. PubMed ID: 10577975
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatments no longer in development for rheumatoid arthritis.
    Keystone E
    Ann Rheum Dis; 2002 Nov; 61 Suppl 2(Suppl 2):ii43-5. PubMed ID: 12379620
    [No Abstract]   [Full Text] [Related]  

  • 17. Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other immune mediated inflammatory diseases (May 2003).
    Furst DE; Breedveld FC; Kalden JR; Smolen JS; Burmester GR; Dougados M; Emery P; Gibofsky A; Kavanaugh AF; Keystone EC; Klareskog L; Russell AS; van de Putte LB; Weisman MH
    Ann Rheum Dis; 2003 Nov; 62 Suppl 2(Suppl 2):ii2-9. PubMed ID: 14532138
    [No Abstract]   [Full Text] [Related]  

  • 18. Joint approach.
    Palmer K
    Minn Med; 2009 Sep; 92(9):22-5. PubMed ID: 19877473
    [No Abstract]   [Full Text] [Related]  

  • 19. Early intervention in rheumatoid arthritis.
    Vasanth LC; Paget SA
    Am J Orthop (Belle Mead NJ); 2007 Jul; 36(7 Suppl):9-10, 15-7. PubMed ID: 17694189
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of rheumatoid arthritis: we are getting there.
    Yazici Y
    Lancet; 2009 Jul; 374(9685):178-80. PubMed ID: 19560809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.